M. Abdelrahman, A. K. Sinha, and A. Karkar, Tuberculosis in endstage renal disease patients on hemodialysis, Hemodial. Int, vol.10, pp.360-364, 2006.

Y. Abe, M. Nakamura, Y. Oshika, H. Hatanaka, T. Tokunaga et al., Serum levels of vascular endothelial growth factor and cavity formation in active pulmonary tuberculosis, Respiration, vol.68, pp.496-500, 2001.

F. Alatas, O. Alatas, M. Metintas, A. Ozarslan, S. Erginel et al., Vascular endothelial growth factor levels in active pulmonary tuberculosis, Chest, vol.125, pp.2156-2159, 2004.

S. Alvarez and W. R. Mccabe, Extrapulmonary tuberculosis revisited: a review of experience at Boston City and other hospitals, Medicine, vol.63, pp.25-55, 1984.

J. Askling, C. M. Fored, L. Brandt, E. Baecklund, L. Bertilsson et al., Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden, Arthritis Rheum, vol.52, 1986.

A. G. Bean, D. R. Roach, H. Briscoe, M. P. France, H. Korner et al., Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin, J. Immunol, vol.162, pp.3504-3511, 1999.

S. Blankley, C. M. Graham, J. Turner, M. P. Berry, C. I. Bloom et al., The transcriptional signature of active tuberculosis reflects symptom status in extra-pulmonary and pulmonary tuberculosis, PLoS One, vol.11, 2016.

O. Bottasso, M. L. Bay, H. Besedovsky, D. Rey, and A. , The immunoendocrine component in the pathogenesis of tuberculosis, Scand. J. Immunol, vol.66, pp.166-175, 2007.

A. A. Cagatay, Y. Caliskan, S. Aksoz, L. Gulec, S. Kucukoglu et al., Extrapulmonary tuberculosis in immunocompetent adults, Scand. J. Infect. Dis, vol.36, pp.799-806, 2004.

P. Carmeliet, Angiogenesis in life, disease and medicine, Nature, vol.438, pp.932-936, 2005.

M. Caws, G. Thwaites, S. Dunstan, T. R. Hawn, N. T. Lan et al., The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis, PLoS Pathog, vol.4, p.1000034, 2008.

M. Chawla, P. Parikh, A. Saxena, M. Munshi, M. Mehta et al., Mycobacterium tuberculosis WhiB4 regulates oxidative stress response to modulate survival and dissemination in vivo, Mol. Microbiol, vol.85, pp.1148-1165, 2012.

D. Dlugovitzky, A. Torres-morales, L. Rateni, M. A. Farroni, C. Largacha et al., Circulating profile of Th1 and Th2 cytokines in tuberculosis patients with different degrees of pulmonary involvement, FEMS Immunol. Med. Microbiol, vol.18, pp.203-207, 1997.

N. Dubois-colas, L. Petit-jentreau, L. B. Barreiro, S. R. Durand, G. Soubigou et al., Extracellular adenosine triphosphate affects the response of human macrophages infected with Mycobacterium tuberculosis, J. Infect. Dis, vol.210, pp.824-833, 2014.

L. B. Edwards, V. T. Livesay, F. A. Acquaviva, P. , and C. E. , Height, weight, tuberculous infection, and tuberculous disease, Arch. Environ. Health Int. J, vol.22, pp.106-112, 1971.

J. D. Ernst, The immunological life cycle of tuberculosis, Nat. Rev. Immunol, vol.12, pp.581-591, 2012.

N. Ferrara, H. Gerber, and J. Lecouter, The biology of VEGF and its receptors, Nat. Med, vol.9, pp.669-676, 2003.

C. T. Fiske, A. S. De-almeida, A. K. Shintani, S. A. Kalams, and T. R. Sterling, Abnormal immune responses in persons with previous extrapulmonary tuberculosis in an in vitro model that simulates in vivo infection with Mycobacterium tuberculosis, Clin. Vaccine Immunol, vol.19, pp.1142-1149, 2012.

M. A. Gardam, E. C. Keystone, R. Menzies, S. Manners, E. Skamene et al., Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management, Lancet Infect. Dis, vol.3, pp.148-155, 2003.

H. P. Gideon, J. Phuah, A. J. Myers, B. D. Bryson, M. A. Rodgers et al., Variability in tuberculosis granuloma T cell responses exists, but a balance of pro-and anti-inflammatory cytokines is associated with sterilization, PLoS Pathog, vol.11, 2015.

M. P. Golden and H. R. Vikram, Extrapulmonary tuberculosis: an overview, Am. Fam. Phys, vol.72, pp.1761-1768, 2005.

J. J. Gomez-reino, L. Carmona, V. R. Valverde, E. M. Mola, and M. D. Montero, Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report, Arthritis Rheum, vol.48, pp.2122-2127, 2003.

O. Y. Gonzalez, G. Adams, L. D. Teeter, T. T. Bui, J. M. Musser et al., Extra-pulmonary manifestations in a large metropolitan area with a low incidence of tuberculosis, Int. J. Tuberc. Lung Dis, vol.7, pp.1178-1185, 2003.

N. Goyal, B. Kashyap, and I. R. Kaur, Significance of IFNg/IL-2 ratio as a circulating diagnostic biomarker in extrapulmonary tuberculosis, Scand. J. Immunol, vol.83, pp.338-344, 2016.

Z. Hasan, B. Jamil, M. Ashraf, M. Islam, M. S. Yusuf et al., ESAT6-induced IFN? and CXCL9 can differentiate severity of tuberculosis, PLoS One, vol.4, p.5158, 2009.

A. C. Helguera-repetto, R. Chacon-salinas, J. F. Cerna-cortes, S. Riveragutierrez, V. Ortiz-navarrete et al., Differential macrophage response to slow-and fast-growing pathogenic mycobacteria, Biomed Res. Int, p.916521, 2014.

A. Invernizzi, F. Franzetti, F. Viola, L. Meroni, and G. Staurenghi, Optic nerve head tubercular granuloma successfully treated with anti-VEGF intravitreal injections in addition to systemic therapy, Eur. J. Ophthalmol, vol.25, pp.270-272, 2015.

E. Iona, M. Pardini, M. C. Gagliardi, M. Colone, A. R. Stringaro et al., Infection of human THP-1 cells with dormant Mycobacterium tuberculosis, Microbes Infect, vol.14, pp.959-967, 2012.

B. Jamil, F. Shahid, Z. Hasan, N. Nasir, T. Razzaki et al., Interferon gamma/IL10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis, Tuberculosis, vol.87, pp.279-287, 2007.

B. E. Jones, M. M. Oo, E. K. Taikwel, D. Qian, A. Kumar et al., CD4 cell counts in human immunodeficiency virus-negative patients with tuberculosis, Clin. Infect. Dis, vol.24, pp.988-991, 1997.

J. Keane, S. Gershon, R. P. Wise, E. Mirabile-levens, J. Kasznica et al., Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent, N. Engl. J. Med, vol.345, pp.1098-1104, 2001.

S. Koch, S. N. Tugues, X. Li, L. Gualandi, C. et al., Signal transduction by vascular endothelial growth factor receptors, Biochem. J, vol.437, pp.169-183, 2011.

N. Krishnan, B. D. Robertson, and G. Thwaites, The mechanisms and consequences of the extra-pulmonary dissemination of Mycobacterium tuberculosis, Tuberculosis, vol.90, pp.361-366, 2010.

J. N. Lin, C. H. Lai, Y. H. Chen, S. S. Lee, S. S. Tsai et al., Risk factors for extra-pulmonary tuberculosis compared to pulmonary tuberculosis, Int. J. Tuberc. Lung Dis, vol.13, pp.620-625, 2009.

P. L. Lin, A. Myers, L. Smith, C. Bigbee, M. Bigbee et al., Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model, Arthritis Rheum, vol.62, pp.340-350, 2010.

E. Martin-mola and A. Balsa, Infectious complications of biologic agents, Rheum. Dis. Clin. North Am, vol.35, pp.183-199, 2009.
DOI : 10.1016/j.rdc.2009.03.009

W. Matsuyama, T. Hashiguchi, K. Matsumuro, F. Iwami, Y. Hirotsu et al., Increased serum level of vascular endothelial growth factor in pulmonary tuberculosis, Am. J. Respir. Crit. Care Med, vol.162, pp.1120-1122, 2000.

W. Matsuyama, T. Hashiguchi, F. Umehara, E. Matsuura, M. Kawabata et al., Expression of vascular endothelial growth factor in tuberculous meningitis, J. Neurol. Sci, vol.186, pp.515-524, 2001.

L. Mayordomo, J. L. Marenco, J. Gomez-mateos, R. , and E. , Pulmonary miliary tuberculosis in a patient with anti-TNF-alpha treatment, Scand. J. Rheumatol, vol.31, pp.44-45, 2002.
DOI : 10.1080/030097402317255372

J. Mazza-stalder, L. Nicod, and J. P. Janssens, Extrapulmonary tuberculosis, Rev. Mal. Respir, vol.29, pp.566-578, 2012.

A. Mihret, Y. Bekele, K. Bobosha, M. Kidd, A. Aseffa et al., Plasma cytokines and chemokines differentiate between active disease and nonactive tuberculosis infection, J. Infect, vol.66, pp.357-365, 2013.
DOI : 10.1016/j.jinf.2012.11.005

U. K. Misra, J. Kalita, A. P. Singh, P. , and S. , Vascular endothelial growth factor in tuberculous meningitis, Int. J. Neurosci, vol.123, pp.128-132, 2013.
DOI : 10.3109/00207454.2012.743127

M. Morosini, F. Meloni, A. Marone-bianco, E. Paschetto, M. Uccelli et al., The assessment of IFN-gamma and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis, Int. J. Tuberc. Lung Dis, vol.7, pp.994-1000, 2003.

S. H. Oehlers, M. R. Cronan, N. R. Scott, M. I. Thomas, K. S. Okuda et al., Interception of host angiogenic signalling limits mycobacterial growth, Nature, vol.517, pp.612-615, 2015.
DOI : 10.1038/nature13967
URL : http://europepmc.org/articles/pmc4312197?pdf=render

I. M. Orme and R. J. Basaraba, The formation of the granuloma in tuberculosis infection, Semin. Immunol, vol.26, pp.601-609, 2014.

M. O. Ota, J. F. Mendy, S. Donkor, T. Togun, M. Daramy et al., Rapid diagnosis of tuberculosis using ex vivo host biomarkers in sputum, Eur. Respir. J, vol.44, pp.254-257, 2014.

K. Pethe, S. Alonso, F. Biet, G. Delogu, M. J. Brennan et al., The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination, Nature, vol.412, pp.190-194, 2001.

H. Polena, F. Boudou, S. Tilleul, N. Dubois-colas, C. Lecointe et al., Mycobacterium tuberculosis exploits the formation of new blood vessels for its dissemination, Sci. Rep, vol.6, p.33162, 2016.

D. Portevin, S. Gagneux, I. Comas, Y. , and D. , Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages, PLoS Pathog, vol.7, p.1001307, 2011.
DOI : 10.1371/journal.ppat.1001307
URL : https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1001307&type=printable

D. Qama, W. I. Choi, and K. Y. Kwon, Immune responses in the lungs of patients with tuberculous pleural effusion without pulmonary tuberculosis, BMC Immunol, vol.13, p.45, 2012.

N. Rakotosamimanana, V. Raharimanga, S. F. Andriamandimby, J. L. Soares, T. M. Doherty et al., Variation in gamma interferon responses to different infecting strains of Mycobacterium tuberculosis in acidfast bacillus smear-positive patients and household contacts in Antananarivo, Madagascar. Clin. Vaccine Immunol, vol.17, pp.1094-1103, 2010.
URL : https://hal.archives-ouvertes.fr/pasteur-00614820

C. J. Riendeau, K. , and H. , THP-1 cell apoptosis in response to mycobacterial infection, Infect. Immun, vol.71, pp.254-259, 2003.

C. Riou, B. Perez-peixoto, L. Roberts, K. Ronacher, G. Walzl et al., Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis, PLoS One, vol.7, p.36886, 2012.

J. K. Roe, N. Thomas, E. Gil, K. Best, E. Tsaliki et al., Blood transcriptomic diagnosis of pulmonary and extrapulmonary tuberculosis, JCI Insight, vol.1, p.87238, 2016.

E. Sahiratmadja, B. Alisjahbana, T. De-boer, I. Adnan, A. Maya et al., Dynamic changes in pro-and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment, Infect. Immun, vol.75, pp.820-829, 2007.

M. Seiscento, F. S. Vargas, M. M. Acencio, L. R. Teixeira, V. L. Capelozzi et al., Pleural fluid cytokines correlate with tissue inflammatory expression in tuberculosis, Int. J. Tuberc. Lung Dis, vol.14, pp.1153-1158, 2010.

N. Sen, T. Turunc, M. Karatasli, S. Sezer, Y. Z. Demiroglu et al., Tuberculosis in patients with end-stage renal disease undergoing dialysis in an endemic region of Turkey, Transplant Proc, vol.40, pp.81-84, 2008.

S. K. Sharma, D. K. Mitra, A. Balamurugan, R. M. Pandey, and N. K. Mehra, Cytokine polarization in miliary and pleural tuberculosis, J. Clin. Immunol, vol.22, pp.345-352, 2002.

S. K. Sharma, M. , and A. , Extrapulmonary tuberculosis, Indian J. Med. Res, vol.120, pp.316-353, 2004.

L. Slutsker, K. G. Castro, J. W. Ward, and S. W. Dooley, Epidemiology of extrapulmonary tuberculosis among persons with AIDS in the United States, Clin. Infect. Dis, vol.16, pp.513-518, 1993.

S. Sousa-vasconcelos-pda, S. Seguins-wda, S. S. Luz-ede, and R. T. Pinho, Pattern of cytokine and chemokine production by THP-1 derived macrophages in response to live or heat-killed Mycobacterium bovis bacillus Calmette-Guerin Moreau strain, Mem. Inst. Oswaldo Cruz, vol.110, pp.809-813, 2015.

A. Spano, S. Barni, and L. Sciola, PMA withdrawal in PMA-treated monocytic THP-1 cells and subsequent retinoic acid stimulation, modulate induction of apoptosis and appearance of dendritic cells, Cell Prolif, vol.46, pp.328-347, 2013.

T. R. Sterling, S. E. Dorman, R. E. Chaisson, L. Ding, J. Hackman et al., Human immunodeficiency virus-seronegative adults with extrapulmonary tuberculosis have abnormal innate immune responses, Clin. Infect. Dis, vol.33, pp.976-982, 2001.
DOI : 10.1086/322670
URL : https://academic.oup.com/cid/article-pdf/33/7/976/1192364/33-7-976.pdf

L. Tailleux, O. Schwartz, J. L. Herrmann, E. Pivert, M. Jackson et al., DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells, J. Exp. Med, vol.197, pp.121-127, 2003.
URL : https://hal.archives-ouvertes.fr/pasteur-01372712

S. M. Thayil, T. A. Albini, H. Nazari, A. A. Moshfeghi, J. M. Parel et al., Local ischemia and increased expression of vascular endothelial growth factor following ocular dissemination of Mycobacterium tuberculosis, PLoS One, vol.6, 2011.

S. A. Theus, M. D. Cave, and K. D. Eisenach, Intracellular macrophage growth rates and cytokine profiles of Mycobacterium tuberculosis strains with different transmission dynamics, J. Infect. Dis, vol.191, pp.453-460, 2005.
DOI : 10.1086/425936
URL : https://academic.oup.com/jid/article-pdf/191/3/453/2386617/191-3-453.pdf

R. Van-crevel, T. H. Ottenhoff, and J. W. Van-der-meer, Innate immunity to Mycobacterium tuberculosis, Clin. Microbiol. Rev, vol.15, pp.294-309, 2002.

M. Van-der-flier, S. Hoppenreijs, A. J. Van-rensburg, M. Ruyken, A. H. Kolk et al., Vascular endothelial growth factor and blood-brain barrier disruption in tuberculous meningitis, Pediatr. Infect. Dis. J, vol.23, pp.608-613, 2004.

R. Vankayalapati, B. Wizel, S. E. Weis, P. Klucar, H. Shams et al., Serum cytokine concentrations do not parallel Mycobacterium tuberculosis-induced cytokine production in patients with tuberculosis, Clin. Infect. Dis, vol.36, pp.24-28, 2003.
DOI : 10.1086/344903
URL : https://academic.oup.com/cid/article-pdf/36/1/24/795642/36-1-24.pdf

R. S. Wallis, Mathematical modeling of the cause of tuberculosis during tumor necrosis factor blockade, Arthritis Rheum, vol.58, pp.947-952, 2008.

C. K. Wong, B. C. Wong, K. C. Chan, G. M. Joynt, F. Y. Yap et al., Cytokine profile in fatal human immunodeficiency virus tuberculosis Epstein-Barr virus associated hemophagocytic syndrome, Arch. Intern. Med, vol.167, pp.1901-1903, 2007.
DOI : 10.1001/archinte.167.17.1901
URL : https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/413051/ilt0924_1901_1903.pdf

K. C. Wong, W. M. Leong, H. K. Law, K. F. Ip, J. T. Lam et al., Molecular characterization of clinical isolates of Mycobacterium tuberculosis and their association with phenotypic virulence in human macrophages, Clin. Vaccine Immunol, vol.14, pp.1279-1284, 2007.

K. Yasui, Immunity against Mycobacterium tuberculosis and the risk of biologic anti-TNF-? reagents, Pediatr. Rheumatol, vol.12, p.45, 2014.

F. C. Zucchi, A. M. Tsanaclis, Q. Moura-dias, C. L. Silva, A. Pelegrini-da-silva et al., Modulation of angiogenic factor VEGF by DNA-hsp65 vaccination in a murine CNS tuberculosis model, Tuberculosis, vol.93, pp.373-380, 2013.

, Conflict of Interest Statement: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest

. Copyright-©-;-ranaivomanana, . Raberahona, . Rabarioelina, . Borella, . Machado et al., This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, 2018.